Cargando…

Antimalarial drug discovery: targeting the hypnozoite for new radical curative agent

Detalles Bibliográficos
Autor principal:	Yeung, Bryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472214/ http://dx.doi.org/10.1186/1475-2875-11-S1-O32

Ejemplares similares

Ethiopian Plasmodium vivax hypnozoites formation dynamics and their susceptibility to reference antimalarial drugs
por: Dembele, Laurent, et al.
Publicado: (2023)

Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug Discovery
por: Dembele, Laurent, et al.
Publicado: (2011)

The global challenge of antimalarial drug resistance
por: Ringwald, Pascal, et al.
Publicado: (2012)

Antimalarial chloroquine metamorphosed into antiviral agent against HIV with four modes of actions
por: Chandramohan, M, et al.
Publicado: (2012)

Estimating the window of selection of antimalarial drugs using field data
por: Winter, Katherine, et al.
Publicado: (2012)

Supply and demand for antimalarial drugs and diagnostic testing in the era of subsidies: multi-country findings
por: Shewchuk, Tanya
Publicado: (2012)

Genomic approaches to drug target discovery using mouse models
por: Morris, DW
Publicado: (2003)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials
por: White, Nicholas J, et al.
Publicado: (2022)

Identification of host interactions for phenotypic antimalarial hits
por: Spitzmüller, Andreas, et al.
Publicado: (2014)

Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010)

Target discovery in the postgenomic era
por: Friedman, L, et al.
Publicado: (2003)

Drug discovery in the p53 pathway
por: Lane, DP, et al.
Publicado: (2000)

A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
por: Maher, S. P., et al.
Publicado: (2023)

Towards a patient-based drug discovery
por: Schreiber, Stuart L
Publicado: (2012)

Role of animal models in oncology drug discovery
por: Kumar, R
Publicado: (2003)

Antimalarial activity of ulein and proof of its action on the Plasmodium falciparum digestive vacuole
por: de Oliveira, Alaíde Braga, et al.
Publicado: (2010)

How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites
por: Huber, John H., et al.
Publicado: (2021)

Dual-Luciferase-Based Fast and Sensitive Detection of Malaria Hypnozoites for the Discovery of Antirelapse Compounds
por: Voorberg-van der Wel, Annemarie M., et al.
Publicado: (2020)

The role of systems modeling in drug discovery and predictive health
por: Voit, Eberhard O
Publicado: (2010)

Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine
por: Flannery, Erika L., et al.
Publicado: (2022)

Prioritization of Molecular Targets for Antimalarial Drug Discovery
por: Forte, Barbara, et al.
Publicado: (2021)

Identification and characterization of novel Plasmodium falciparum cyclophilins and their roles in the antimalarial actions of cyclosporin A and derivatives
por: Marin-Menendez, Alejandro, et al.
Publicado: (2010)

New agents for bone metastasis
por: Hortobagyi, GN
Publicado: (2005)

Hypnozoite depletion in successive Plasmodium vivax relapses
por: Noviyanti, Rintis, et al.
Publicado: (2022)

Natural product-likeness score and its applications in the drug discovery process
por: Ertl, Peter, et al.
Publicado: (2008)

CADDSuite – a workflow-enabled suite of open-source tools for drug discovery
por: Kohlbacher, Oliver
Publicado: (2012)

Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

The FRAGILOME project, a strategy for the discovery of new gene biomarkers in cancer
por: Schwab, Manfred
Publicado: (2010)

OA02.08. Chick embryo model an experimental model for drug discovery in ayurveda.
por: Tomar, Ekta, et al.
Publicado: (2013)

Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
por: White, Michael T, et al.
Publicado: (2014)

New cytokinin derivatives – their discovery, development and use for micropropagation of endangered tree species
por: Dolezal, Karel, et al.
Publicado: (2011)

Encryptomics: how Aristotle's causality system can be applied to new molecule discovery
por: Junior, Carlos Bloch
Publicado: (2014)

Pluripotent stem cells for pathological modelling of Hutchinson-Gilford Progeria Syndrome (HGPS) and drug discovery
por: Nissan, Xavier
Publicado: (2015)

S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria.
por: Vij, Raghav, et al.
Publicado: (2022)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

Simultaneous reconstructive surgery for radical mastectomy
por: Robb, PG
Publicado: (2005)

A Radical Approach To Diagnosing Infection
por: MacCallum, N, et al.
Publicado: (2015)

Antimalarial drug discovery: progress and approaches
por: Siqueira-Neto, Jair L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4rf7vjmq6igk7ubkun52l3ualr